Embree Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$890K Buy
6,928
+43
+0.6% +$5.03K 0.09% 131
2026
Q1
$828K Buy
6,885
+1,968
+40% +$227K 0.1% 126
2025
Q4
$518K Sell
4,917
-532
-10% -$49.9K 0.06% 152
2025
Q3
$457K Sell
5,449
-222
-4% -$18.3K 0.06% 147
2025
Q2
$449K Sell
5,671
-297
-5% -$23.6K 0.07% 140
2025
Q1
$536K Buy
5,968
+1,617
+37% +$151K 0.09% 128
2024
Q4
$433K Buy
4,351
+197
+5% +$20.3K 0.07% 127
2024
Q3
$472K Sell
4,154
-85
-2% -$10.1K 0.08% 122
2024
Q2
$525K Buy
4,239
+11
+0.3% +$1.42K 0.1% 109
2024
Q1
$558K Sell
4,228
-294
-7% -$36.2K 0.11% 111
2023
Q4
$493K Buy
+4,522
New +$469K 0.1% 112

Other funds holding MRK

Embree Financial Group's MRK Position: Q2 2026 in Review

Embree Financial Group increased its Merck (MRK) stake by 0.62% in Q2 2026, buying an estimated $5.03K and bringing the position to 6,928 shares worth $890K. The position accounts for 0.09% of the portfolio, ranked #131.

Embree Financial Group first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Embree Financial Group held 6,928 shares of Merck worth $890K as of Q2 2026.
  • Embree Financial Group bought 43 Merck shares in Q2 2026, an estimated $5.03K.
  • Merck made up 0.09% of Embree Financial Group's portfolio in Q2 2026, its #131 holding.
  • Embree Financial Group first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.